Artigo de periodico

Combating bacterial resistance to antimicrobials in severe septic ICU patients: importance of meropenem, piperacillin serum monitoring as a dose adjustment and duration of infusion strategies (2023)

• Authors:
  • Santos, Silvia Regina Cavani Jorge
  • Camargo, Thais Vieira de
  • Messiano, Claudia Garcia
  • Kupa, Leonard de Vinci Kanda
  • Souza, Vanessa Kasubeck de
  • Morales Júnior, Ronaldo
  • Pinto, Débora Cristina Sanches
  • Silva Junior, Elson Mendes da
  • Silva Júnior, João Manoel da
  • Gómez, David de Souza
• USP affiliated authors: SANTOS, SILVIA REGINA CAVANI JORGE - FCF ; SILVA JUNIOR, JOÃO MANOEL DA - FM ; GOMEZ, DAVID DE SOUZA - FM ; KUPA, LEONARD DE VINCI KANDA - FM ; MORALES JUNIOR, RONALDO - FCF ; PINTO, DÉBORA CRISTINA SANCHES - FM ; SILVA JÚNIOR, ELSON MENDES DA - FM
• Unidades: FCF; FM
• Subjects: FARMACOCINÉTICA; FARMACODINÂMICA
• Language: Inglês
• Imprenta:
  • Publisher place: Oklahoma
  • Date published: 2023
• Source:
  • Título: Pharmacy & Pharmacology International Journal
  • ISSN: 2379-6367
  • Volume/Número/Paginação/Ano: v. 11, n. 2, p. 52-60, 2023


---

Download do texto completo

Tipo	Nome	Link
	3151265.pdf	Direct link

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  SANTOS, Silvia Regina Cavani Jorge et al. Combating bacterial resistance to antimicrobials in severe septic ICU patients: importance of meropenem, piperacillin serum monitoring as a dose adjustment and duration of infusion strategies. Pharmacy & Pharmacology International Journal, v. 11, n. 2, p. 52-60, 2023Tradução . . Disponível em: https://medcraveonline.com/PPIJ/PPIJ-11-00402.pdf. Acesso em: 02 jan. 2026.

• APA

  Santos, S. R. C. J., Camargo, T. V. de, Messiano, C. G., Kupa, L. de V. K., Souza, V. K. de, Morales Júnior, R., et al. (2023). Combating bacterial resistance to antimicrobials in severe septic ICU patients: importance of meropenem, piperacillin serum monitoring as a dose adjustment and duration of infusion strategies. Pharmacy & Pharmacology International Journal, 11( 2), 52-60. Recuperado de https://medcraveonline.com/PPIJ/PPIJ-11-00402.pdf

• NLM

  Santos SRCJ, Camargo TV de, Messiano CG, Kupa L de VK, Souza VK de, Morales Júnior R, Pinto DCS, Silva Junior EM da, Silva Júnior JM da, Gómez D de S. Combating bacterial resistance to antimicrobials in severe septic ICU patients: importance of meropenem, piperacillin serum monitoring as a dose adjustment and duration of infusion strategies [Internet]. Pharmacy & Pharmacology International Journal. 2023 ; 11( 2): 52-60.[citado 2026 jan. 02 ] Available from: https://medcraveonline.com/PPIJ/PPIJ-11-00402.pdf

• Vancouver

  Santos SRCJ, Camargo TV de, Messiano CG, Kupa L de VK, Souza VK de, Morales Júnior R, Pinto DCS, Silva Junior EM da, Silva Júnior JM da, Gómez D de S. Combating bacterial resistance to antimicrobials in severe septic ICU patients: importance of meropenem, piperacillin serum monitoring as a dose adjustment and duration of infusion strategies [Internet]. Pharmacy & Pharmacology International Journal. 2023 ; 11( 2): 52-60.[citado 2026 jan. 02 ] Available from: https://medcraveonline.com/PPIJ/PPIJ-11-00402.pdf

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Bioanalytical methods based on liquid chromatography for the therapeutic drug monitoring of combined therapies of antibiotics in pediatric septic major burns
• Combined vancomycin-meropenem therapy in pediatric major burns undergoing therapy of septic shock guided by cultures and pharmacokinetic-pharmacodynamics approach based on serum levels to combat bacterial resistance
• Beta-lactam agents serum measurements by liquid chromatography to evaluate meropenem and piperacillin effectiveness in septic burn adults with a pharmacokinetic-pharmacodynamic approach
• Liquid chromatography-tandem mass spectrometry for simultaneous piperacillin-meropenem serum measurements in septic burns for effectiveness
• Therapeutic target attainment of 3-Hour extended Infusion of Meropenem in patients with septic burns
• Farmacocinética clínica aplicada à otimização de farmacoterapia
• Vancomycin dose adjustment in critically ill burn patients using the pharmacokinetic/pharmacodynamic approach against Gram-positive MIC 2 mg/l strains
• Antimicrobial therapy in severe septic ICU major burn patients to combat bacterial resistance by pharmacokinetic-pharmacodymamics of vancomycin, meropenem, and piperacillin, cultures, and inflammatory biomarkers
• Meropenem extended infusion to guarantee drug effectiveness against nosocomial MIC 4 mg/l strains in burn patients at the earlier period of septic shock
• The pharmacokinetic/pharmacodynamic approach in pediatric septic burn patients to guarantee vancomycin effectiveness against Staphylococcus